Yarrow Bioscience Inc
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-26.5M | $-39.8M | $-28.5M | $-23.2M | $-73.3M | $-255.6M | $-95.2M | $-74.2M |
| Depreciation & Amortization | $23.0K | $4.0K | $0 | $72.0K | $109.0K | $341.0K | $350.0K | $319.0K |
| Depreciation | $23.0K | $4.0K | $0 | $100.0K | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $2.3M | $3.3M | $3.3M | $4.3M | $8.1M | $18.1M | $4.9M | $5.3M |
| Net Cash from Operating Activities | $-33.1M | $-34.0M | $-25.3M | $-29.2M | $-56.4M | $-137.1M | $-73.4M | $-68.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $117.0K | $0 | — | $0 | $113.0K | $1.1M | $567.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $37.4M | $23.4M | $-57.4M | $15.7M | $1.0M | $89.1M | $41.9M | $-11.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-143.0K | $-141.0K | $82.4M | $1.7M | $39.8M | $61.8M | $48.0M | $92.4M |
| Net Change in Cash | $4.1M | $-10.7M | $-301.0K | — | — | — | $-18.7M | $39.3M |
| Free Cash Flow | $-33.1M | $-34.1M | $-25.3M | — | $-56.4M | $-137.2M | $-74.5M | $-69.2M |